Mankind Pharma today launched “Act at 30 – It’s Time for a Heart Check,” a nationwide preventive health movement aimed at redefining when cardiovascular vigilance must begin, shifting the focus to age 30. Emerging clinical evidence indicates that nearly one in four Indians aged 30–39 may
Acquires exclusive rights to manufacture, market and distribute Rivotril in India Adds a clonazepam Textbook brand with strong clinical legacy and specialist recall Strengthens Mankind Pharma’s strategic focus on chronic and CNS therapies Creates a platform for future expansion through potential line extensions Mankind Pharma
New Delhi, [Date]: On the occasion of World Kidney Day, Mankind Pharma, in association with leading healthcare experts, is calling for greater awareness around kidney health, highlighting that chronic kidney disease (CKD) affects nearly 10% of the global population and is often detected only at
PregaNews, India’s No.1 pregnancy detection brand, by Mankind Pharma, trusted by millions of women and gynaecologists, has launched a new digital film ahead of International Women’s Day to encourage open conversations around postpartum experiences, a phase often overlooked despite being one of the most emotionally and physically
Mankind Pharma, India’s fourth-largest pharmaceutical company, has completed a large-scale, multi-year transformation of its global supply chain and strategic procurement function to strengthen access to medicines, improve supply reliability, and support disciplined, scalable growth. Delivered in collaboration with Accenture, the integrated initiative embeds digitally enabled
National, 4th December 2025: Mankind Pharma, one of India's leading pharmaceutical companies, today announced the launch of PetStar Delight, expanding its PetStar brand into the cat food segment. The new range is formulated to support overall feline wellness and marks a significant milestone in the
Covers exclusive rights to S-pindolol, the novel therapy in development for the treatment of cachexia, in India and South Asia Represents a major step in the mission of Actimed to bring the first globally approved cancer cachexia product to patients in need Actimed Therapeutics Ltd (“Actimed”), a
Mankind Pharma, India’s fourth largest pharmaceutical company, today announced a collaboration with OpenAI, a leading AI research and deployment company, to institutionalize AI across its value chain. As one of the first few Indian pharma companies to fully integrate advanced AI into core operations, Mankind
Mankind Pharma Ltd., India’s 4th largest pharmaceutical company, today announced that it has received approval from the Central Drugs Standard Control Organisation (CDSCO) to initiate a Phase 1 clinical trial of MKP11093, a novel, orally administered Janus kinase-1 (JAK-1) inhibitor. The molecule is being developed
Mankind Pharma, India’s fourth largest pharma company, has launched a powerful video campaign featuring legendary actor Amitabh Bachchan to raise awareness about organ donation on World Organ Donation Day. The campaign themed "Live Beyond Your Life" aims to address India's critically low organ donation rates
